PERFORMANCE AND CLINICAL UTILITY OF A COMMERCIALLY AVAILABLE C-TERMINAL PTH ASSAY

被引：10

作者：

INGLE, AR

BAILEY, JE

MATTHEWS, HL

HARROP, JS

机构：

[1] DERBYSHIRE ROYAL INFIRM,DEPT CHEM PATHOL,DERBY DE1 2QY,ENGLAND

[2] DERBYSHIRE ROYAL INFIRM,DEPT MED,DERBY DE1 2QY,ENGLAND

来源：

ANNALS OF CLINICAL BIOCHEMISTRY | 1986年 / 23卷

关键词：

D O I：

10.1177/000456328602300409

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：434 / 439

页数：6

共 25 条

[1] CONTROL OF SECRETION OF PARATHYROID-HORMONE IN SECONDARY HYPERPARATHYROIDISM [J].

ADAMI, S ;

MUIRHEAD, N ;

MANNING, RM ;

GLEED, JH ;

PAPAPOULOS, SE ;

SANDLER, LM ;

CATTO, GRD ;

ORIORDAN, JLH .

CLINICAL ENDOCRINOLOGY, 1982, 16 (05) :463-473

[2] INFLUENCE OF IMMUNOHETEROGENEITY OF CIRCULATING PARATHYROID-HORMONE ON RESULTS OF RADIOIMMUNOASSAYS OF SERUM IN MAN [J].

ARNAUD, CD ;

GOLDSMITH, RS ;

BORDIER, PJ ;

SIZEMORE, GW ;

LARSEN, JA ;

GILKINSO.J .

AMERICAN JOURNAL OF MEDICINE, 1974, 56 (06) :785-793

[3]

BERSON SA, 1968, J CLIN ENDOCR METAB, V28, P1037

[4] IMMUNOASSAY OF BOVINE AND HUMAN PARATHYROID HORMONE [J].

BERSON, SA ;

AURBACH, GD ;

POTTS, JT ;

YALOW, RS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1963, 49 (05) :613-&

[5]

Buchanan G, 1975, Clin Oncol, V1, P89

[6]

DIBELLA FP, 1982, CLIN CHEM, V28, P226

[7]

DREZNER MK, 1978, LANCET, V1, P1004

[8]

HABENER JF, 1979, ANN INTERN MED, V19, P782

[9] INCIDENCE OF HYPERCALCEMIA AND PRIMARY HYPERPARATHYROIDISM IN RELATION TO THE BIOCHEMICAL PROFILE [J].

HARROP, JS ;

BAILEY, JE ;

WOODHEAD, JS .

JOURNAL OF CLINICAL PATHOLOGY, 1982, 35 (04) :395-400

[10]

HEATH DA, 1982, CLIN ENDOCRINOLOGY, V2, P233

← 1 2 3 →